Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

Perianal Abscess Tied to Crohn's Disease Risk in Older Kids

Older children with perianal abscess or fistula-in-ano, especially those with recurrent perianal abscess or fistula-in-ano or gastrointestinal symptoms, are more likely to develop Crohn's disease.

Bimekizumab Not Tied to Mental Health Risk, Study Suggests

A study suggests that bimekizumab does not increase the risk for depression or suicidal ideation compared with IL-23 inhibitors in adults with psoriasis.

Should Biology Replace Organ Labels in Cancer Treatment?

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

PIP Matches PrEP for Low-Risk HIV

The use of medicine at home offers convenience and curbs costs.

Can Physical Activity Improve Skin Cancer Outcomes?

Physical activity is associated with a reduced risk for all-cause mortality and improved survival in patients with skin cancer, a meta-analysis shows.

Healthy Diet May Cut Cancer Survivors’ Premature Aging Risk

A recent study found reduced premature aging among childhood cancer survivors that adhered to established dietary guidelines.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Todays Updates

Neoadjuvant GOLP Boosts Event-Free Survival in Liver Cancer

A phase 2/3 trial evaluates the efficacy and safety of neoadjuvant therapy with gemcitabine-oxaliplatin, lenvatinib, and toripalimab in patients with high-risk intrahepatic cholangiocarcinoma.

Risk Factors Driving Severe Maternal Morbidity in the US

Hypertensive disorders of pregnancy, chronic hypertension, and obesity are the primary risk factors for severe maternal morbidity.

CUD, Depression Share Bidirectional Link

Cannabis use disorder has a bidirectional and clinically meaningful association with major depressive disorder, new research suggests.

Medicaid Expansion Tied to Pancreatic Cancer Survival

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic cancer.

Can Upadacitinib Improve Sleep Quality in Patients With RA?

Upadacitinib may improve self-reported sleep quality at 3 months in patients with rheumatoid arthritis, with sustained benefits seen over the long term.

Novel Drug Duo Preserves Bladder in Muscle-Invasive Cancer

Approximately 40% of patients with muscle-invasive bladder cancer achieve a clinical complete response after neoadjuvant sacituzumab govitecan plus pembrolizumab, the SURE-02 trial finds.

Exploring Whether GLP-1 Medications May Cause Sinusitis

Research is limited, but what has been done shows a possible connection.

Latest News

Older children with perianal abscess or fistula-in-ano, especially those with recurrent perianal abscess or fistula-in-ano or gastrointestinal symptoms, are more likely to develop Crohn's disease.

A study suggests that bimekizumab does not increase the risk for depression or suicidal ideation compared with IL-23 inhibitors in adults with psoriasis.

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

The use of medicine at home offers convenience and curbs costs.

Physical activity is associated with a reduced risk for all-cause mortality and improved survival in patients with skin cancer, a meta-analysis shows.

A recent study found reduced premature aging among childhood cancer survivors that adhered to established dietary guidelines.

News All Time

Americans Trust Vaccines, School Mandates, Rejecting Trump Agenda, Reuters/Ipsos Poll Finds

A bipartisan majority of Americans believe vaccines are safe and that children should receive them to attend school, according to a new Reuters/Ipsos poll, illustrating the...

New Mental Health Disorders Tied to Early Cancer Mortality

In a decade-long analysis of University of California health system data, researchers assess early-onset mental health disorders after cancer diagnosis and subsequent survival trends.

NHS to Fund Ruxolitinib for Vitiligo

NICE has recommended topical ruxolitinib for facial non-segmental vitiligo in patients aged 12 or over after a revised cost review.

Lipedema Is Now Recognized as a Chronic Disease

International consensus defines lipedema as a chronic disease; clarifies its biology and diagnosis; and urges standardized care, research, and policy action.

Lilly's Zepbound and Taltz Improve Psoriasis Symptoms, Drive Weight Loss in Study

Eli Lilly said on Wednesday its weight-loss drug, Zepbound, used with psoriasis treatment Taltz, showed ⁠better results in patients with the skin disease and obesity in a...

Bimekizumab Eases Plaque Psoriasis Symptoms Up to 3 Years

Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.

Amivantamab Tied to Diverse Dermatologic Events in NSCLC

Treatment with amivantamab is associated with a broad spectrum of dermatologic adverse events that can be severe in patients with non-small cell lung cancer, a real-world study shows.

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Exploring Cutting-Edge Data for New and Emerging Treatments in Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Ask the Experts: The Latest Updates in the Pathophysiology and Targeted Treatment of Chronic Spontaneous Urticaria

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Navigating Chronic Spontaneous Urticaria Diagnosis, Assessment, and Treatment Selection

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Advancing Immune Checkpoint Inhibitor Use in Resectable Melanoma

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

Inside Idiopathic Inflammatory Myopathies (IIMs): From Pathophysiology to Presentation

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Clinical Suspicion to Classification of Idiopathic Inflammatory Myopathies (IIMs): Biomarkers and Diagnostic Best Practices

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

From Unmet Needs to Targeted Intervention: Evolving Treatment Strategies in Idiopathic Inflammatory Myopathies (IIMs)

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

Collaborative Clinical Conversations: A Virtual Tumor Board Case Challenge on Immunotherapy in Resectable Melanoma

AAD: American Academy of Dermatology

Recommended News For You

MCh in Surgical Oncology: Admission, Medical School, Fees, Qualifications Information

Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

The risk of cancer is decreased by following international health recommendations.

Recommended Articles For You

Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment  

Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation 

An Analytical and Statistical Journey through Genomic Revolution, Novel Therapeutics, and Future Horizons in Lymphoma 2025 

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Global warming could be driving up women's cancer risk, find researchers

2.

More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.

3.

Using MRD Status to Deescalate Multiple Myeloma Therapy

4.

Kidney cancer: Understanding what a renal cell carcinoma diagnosis means

5.

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

1.

Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options 

2.

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025

3.

Exploring the Latest Advances in PTLD Cancer Treatment

4.

Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights

5.

Mechanisms, Efficacy, and Survival Outcomes in AML, Squamous Cell Carcinoma, & Non-Hodgkin Lymphoma

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Oropharyngeal Cancer in Relation to HPV Status

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot